D L Carlson Investment Group Inc. Has $8.05 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

D L Carlson Investment Group Inc. cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,421 shares of the medical equipment provider’s stock after selling 544 shares during the quarter. Intuitive Surgical makes up 1.4% of D L Carlson Investment Group Inc.’s portfolio, making the stock its 15th biggest holding. D L Carlson Investment Group Inc.’s holdings in Intuitive Surgical were worth $8,049,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of ISRG. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth about $25,000. Berbice Capital Management LLC acquired a new position in Intuitive Surgical in the fourth quarter worth approximately $26,000. BankPlus Trust Department bought a new position in Intuitive Surgical during the fourth quarter valued at approximately $28,000. Summit Securities Group LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $30,000. Finally, Kohmann Bosshard Financial Services LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth $31,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Raymond James lifted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. JPMorgan Chase & Co. upped their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Jefferies Financial Group raised their price objective on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Wells Fargo & Company upped their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Bernstein Bank boosted their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $491.84 on Monday. The stock has a market capitalization of $175.18 billion, a PE ratio of 76.73, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The stock has a 50 day moving average price of $556.28 and a 200 day moving average price of $532.97.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.